J

Jade Biosciences Inc
D

JBIO

16.900
USD
-0.81
(-4.57%)
مغلق
حجم التداول
46,983
الربح لكل سهم
-2
العائد الربحي
-
P/E
-6
حجم السوق
1,003,181,887
أصول ذات صلة المقالات
المزيد

العنوان: Jade Biosciences Inc

القطاع: Healthcare
الصناعة: Biotechnology
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.